These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29625132)

  • 1. Modernizing regulation of cosmetic products: Reintroduction of the Personal Care Products Safety Act.
    Nguyen HP; Bergfeld WF; Forman HP; Belsito DV; Bolognia JL
    J Am Acad Dermatol; 2018 Aug; 79(2):403-405. PubMed ID: 29625132
    [No Abstract]   [Full Text] [Related]  

  • 2. Time for a makeover-cosmetics regulation in the United States.
    Cornell EM; Janetos TM; Xu S
    J Cosmet Dermatol; 2019 Dec; 18(6):2041-2047. PubMed ID: 30950176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cosmetic/drug dilemma: FDA regulation of alpha-hydroxy acids.
    Heymann LA
    Food Drug Law J; 1997; 52(4):357-75. PubMed ID: 10346670
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanotechnology in cosmetics.
    Katz LM; Dewan K; Bronaugh RL
    Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cosmetics that are also drugs.
    Greff JA
    Food Drug Law J; 1996; 51(2):243-72. PubMed ID: 11820201
    [No Abstract]   [Full Text] [Related]  

  • 6. American beauty: an analytical view of the past and current effectiveness of cosmetic safety regulations and future direction.
    Termini RB; Tressler L
    Food Drug Law J; 2008; 63(1):257-74. PubMed ID: 18561461
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety evaluations under the proposed US Safe Cosmetics and Personal Care Products Act of 2013: animal use and cost estimates.
    Knight J; Rovida C
    ALTEX; 2014; 31(2):177-208. PubMed ID: 24468774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is it time to revise CFR title 21-Food Drugs & Cosmetics Act for skin care products?
    Epstein HA
    Skinmed; 2013; 11(5):297-9. PubMed ID: 24340471
    [No Abstract]   [Full Text] [Related]  

  • 9. Adverse Events Reported to the US Food and Drug Administration for Cosmetics and Personal Care Products.
    Kwa M; Welty LJ; Xu S
    JAMA Intern Med; 2017 Aug; 177(8):1202-1204. PubMed ID: 28654953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Federal preemption of common law tort awards by the Federal Food, Drug, and Cosmetic Act.
    Carrier MK
    Food Drug Law J; 1996; 51(4):509-611. PubMed ID: 11797729
    [No Abstract]   [Full Text] [Related]  

  • 11. The US Food and Drug Administration Modernization Act of 1997: impact on consumers.
    Golodner LF
    Clin Ther; 1998; 20 Suppl C():C20-5. PubMed ID: 9915086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The little agency that could (act with indifference to constitutional and statutory strictures).
    Noah L
    Cornell Law Rev; 2008 Jul; 93(5):901-26. PubMed ID: 18618963
    [No Abstract]   [Full Text] [Related]  

  • 13. Globalization of cosmetic regulations.
    Blaschke JW
    Food Drug Law J; 2005; 60(3):413-9. PubMed ID: 16304748
    [No Abstract]   [Full Text] [Related]  

  • 14. The Personal Care Products Safety Act.
    Feinstein D; Collins S
    JAMA Intern Med; 2018 May; 178(5):601-602. PubMed ID: 29404567
    [No Abstract]   [Full Text] [Related]  

  • 15. Is it a cosmetic, a drug, or both? (Or is it soap?).
    Center for Safety and Applied Nutrition/Office of Cosmetics and Colors US Food and Drug Administration
    Plast Surg Nurs; 2008; 28(4):195-7. PubMed ID: 19092587
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticipating new consumer protection challenges in the food and drug marketplace.
    Parnes LB
    Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cosmetic products : Safety aspects].
    Platzek T; Krätke R; Schulz C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jun; 53(6):610-4. PubMed ID: 20464352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating drugs for effectiveness and safety: a public health perspective.
    Zito JM; Socolar SJ; Eilers R; Crystal S; Lexchin J
    Med Care; 2007 Sep; 45(9):911. PubMed ID: 17712264
    [No Abstract]   [Full Text] [Related]  

  • 19. Dirty dancing--the FDA stumbles with the Chevron two-step: a response to professor Noah.
    Lawson G
    Cornell Law Rev; 2008 Jul; 93(5):927-38. PubMed ID: 18618964
    [No Abstract]   [Full Text] [Related]  

  • 20. Reading our lips: the history of lipstick regulation in Western seats of power.
    Schaffer SE
    Food Drug Law J; 2007; 62(1):165-225. PubMed ID: 17444030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.